Thrombus formation on transcatheter ASD occluder device in a patient with coagulation factor XII deficiency

作者: Oliver Gastmann , Gerald S. Werner , Uros U. Babic , Hans R. Figulla

DOI: 10.1002/(SICI)1097-0304(199801)43:1<81::AID-CCD24>3.0.CO;2-V

关键词:

摘要: Transcatheter occlusion of cardiac defects has become an effective and less invasive alternative to open heart surgery. Thromboembolic complications are rare events, after both surgical transcatheter closure atrial septal [Galal et al.: Eur Heart J 15:1381–1384, 1994]. We report on a case thrombus formation the defect occluder system (ASDOS) [Sievert Cathet Cardiovasc Diagn 36:232–240, 1995; Hausdorf 75:83–88, 1996]. Two days occlusion, patient suffered acute stroke due embolism despite anticoagulation with intravenous heparin. A coagulation disorder reduced factor XII concentration was deduced as likely cause. Repeated transesophageal echocardiographic (TEE) studies revealed involution intracardial within weeks subsequent anticoagulatory treatment. Firstoff, this shows that patients deficiency at risk for thromboembolism. Second, it again clarifies even large amounts intraartrial thrombotic material may not be seen by transthoracic echocardiography (TTE) underscores necessity performing TEE. Screening disorders (Quick's value (Q), partial thromboplastin time (PTT)) before they selected treatment thrombogenic devices is indispensable. With regard their personal history (earlier thromboembolism) result screening (e.g., prolongation PTT), quantitative determination factors reasonable. If endangered thromboembolic nevertheless undergo ASD procedures, monitoring requires exceptional attention. Furthermore, recommended TEE should carried out in these 2 treatment, since might unable detect device. Cathet. Cardiovasc. Diagn. 43:81–83, 1998. © 1998 Wiley-Liss, Inc.

参考文章(8)
Horst Sievert, Uros U. Babic, Roland Ensslen, Detlef Scherer, Hans Spies, Thomas Wiederspahn, Harald E. Zeplin, Transcatheter closure of large atrial septal defects with the babic system Catheterization and Cardiovascular Diagnosis. ,vol. 36, pp. 232- 240 ,(1995) , 10.1002/CCD.1810360309
HELEN I. GLUECK, Myocardial Infarction in a Patient with a Hageman (Factor XII) Defect Annals of Internal Medicine. ,vol. 64, pp. 390- 396 ,(1966) , 10.7326/0003-4819-64-2-390
Victor G. Davila-Roman, Bill B. Daily, Suzan F. Murphy, Kenneth B. Schechtman, Benico Barzilai, Nicholas T. Kouchoukos, Thomas H. Wareing, Strategy for the reduction of stroke incidence in cardiac surgical patients The Annals of Thoracic Surgery. ,vol. 55, pp. 1400- 1408 ,(1993) , 10.1016/0003-4975(93)91079-3
Walter-Michael Halbmayer, Alexander Haushofer, Johannes Radek, Renate Schön, Manfred Deutsch, Michael Fischer, Prevalence of factor XII (Hageman factor) deficiency among 426 patients with coronary heart disease awaiting cardiac surgery. Coronary Artery Disease. ,vol. 5, pp. 451- 454 ,(1994) , 10.1097/00019501-199405000-00012
M. Winter, M. Gallimore, D.W. Jones, Should factor XII assays be included in thrombophilia screening? The Lancet. ,vol. 346, pp. 52- ,(1995) , 10.1016/S0140-6736(95)92682-8
G. Hausdorf, M. Schneider, B. Franzbach, C. Kampmann, K. Kargus, B. Goeldner, Transcatheter closure of secundum atrial septal defects with the atrial septal defect occlusion system (ASDOS): initial experience in children. Heart. ,vol. 75, pp. 83- 88 ,(1996) , 10.1136/HRT.75.1.83
M. O. GALAL, A. WOBST, Z. HALEES, L. HATLE, A. A. SCHMALTZ, F. KHOUGEER, E. DE VOL, M. E. FAWZY, F. ABBAG, F. FADLEY, C. M. G. DURAN, Peri-operative complications following surgical closure of atrial septal defect type II in 232 patients—a baseline study European Heart Journal. ,vol. 15, pp. 1381- 1384 ,(1994) , 10.1093/OXFORDJOURNALS.EURHEARTJ.A060398
C Negrier, M C Delmas, B Ranchin, P Cochat, M Dechavanne, Decreased factor XII activity in a child with nephrotic syndrome and thromboembolic complications. Thrombosis and Haemostasis. ,vol. 66, pp. 512- 513 ,(1991) , 10.1055/S-0038-1646450